Eyebright Medical Technology (Beijing) Co., Ltd.

XSSC:688050 Stock Report

Market Cap: CN¥17.1b

Eyebright Medical Technology (Beijing) Balance Sheet Health

Financial Health criteria checks 5/6

Eyebright Medical Technology (Beijing) has a total shareholder equity of CN¥2.5B and total debt of CN¥614.8M, which brings its debt-to-equity ratio to 24.2%. Its total assets and total liabilities are CN¥3.4B and CN¥863.1M respectively. Eyebright Medical Technology (Beijing)'s EBIT is CN¥412.0M making its interest coverage ratio 34.3. It has cash and short-term investments of CN¥469.3M.

Key information

24.2%

Debt to equity ratio

CN¥614.83m

Debt

Interest coverage ratio34.3x
CashCN¥469.25m
EquityCN¥2.54b
Total liabilitiesCN¥863.14m
Total assetsCN¥3.41b

Recent financial health updates

No updates

Recent updates

Financial Position Analysis

Short Term Liabilities: 688050's short term assets (CN¥1.2B) exceed its short term liabilities (CN¥247.5M).

Long Term Liabilities: 688050's short term assets (CN¥1.2B) exceed its long term liabilities (CN¥615.6M).


Debt to Equity History and Analysis

Debt Level: 688050's net debt to equity ratio (5.7%) is considered satisfactory.

Reducing Debt: 688050's debt to equity ratio has increased from 0.1% to 24.2% over the past 5 years.

Debt Coverage: 688050's debt is well covered by operating cash flow (48.6%).

Interest Coverage: 688050's interest payments on its debt are well covered by EBIT (34.3x coverage).


Balance Sheet


Discover healthy companies